MP04: Kidney Cancer: Basic Research & Pathophysiology I

Poster Session Moderator(s)

• PC

  Peter Clark, MD

  Professor and Chair
  Atrium Health and Levine Cancer Institute

Podium Session Moderator(s)

• AH

  A. Hakimi, MD

Poster Session Moderator(s)

• 

  Vitaly Margulis, MD

  UT Southwestern Medical Center

Presentations:

• 7:00 AM – 9:00 AM CST

  MP04-01: Biomarkers of Disease Burden and Treatment Response in Renal Medullary Carcinoma
  

  Poster Presenter: Kyle Blum
• 7:00 AM – 9:00 AM CST

  MP04-02: Bacteria-derived DNA in extracellular vesicles of serum could become a novel diagnostic biomarker for renal cell carcinoma
  

  Poster Presenter: Toshihiro Uemura – Department of Urology, Osaka University, Grad
• 7:00 AM – 9:00 AM CST

  MP04-03: Exosomal lncRNA BCYRN1 can be a target for diagnosis and therapy in renal cell carcinoma
  

  Poster Presenter: Hirofumi Yoshino
• 7:00 AM – 9:00 AM CST

  MP04-04: PD-L1 Expression and Renal Cell Carcinoma: Is Exogenous Estrogen Driving Aggressive Tumor Characteristics Through Increased Oncologic Exosome Production?
  

  Poster Presenter: Jacob W. Greenberg
• 7:00 AM – 9:00 AM CST

  MP04-05: NF2-Mutant Renal Cell Carcinoma: A Clinical and Genomic Characterization of An Unclassified Carcinoma
  

  Poster Presenter: Stephen Reese, MD – Memorial Sloan Kettering Cancer Center
• 7:00 AM – 9:00 AM CST

  MP04-07: Volatilome Analysis in Renal Cancer by Electronic Nose: A Pilot Monocentric Study
  

  Poster Presenter: Manuela Costantini, MD,Phd (she/her/hers) – IRCCS Regina Elena National Cancer Institute
• 7:00 AM – 9:00 AM CST

  MP04-08: Comprehensive analysis of copy number variation and sensitivity to targeted therapy in renal cell carcinoma using in-house cancer gene panel testing
  

  Poster Presenter: Akhito Takeutchi – Fujita Health University
• 7:00 AM – 9:00 AM CST

  MP04-09: Novel Inhibitor of Pro-survival Protein Phosphatase 5 (PP5) Leads to Apoptosis in Clear Cell Renal Cell Carcinoma
  

  Poster Presenter: Rebecca A. Sager, MD, PHD
• 7:00 AM – 9:00 AM CST

  MP04-10: Machine learning predicts metabolic biomarkers of response to anti-VEGF drug sunitinib in ccRCC
  

  Poster Presenter: Amy X. Xie, BS (she/her/hers)
• 7:00 AM – 9:00 AM CST

  MP04-11: Targeting glutamine addiction with potent drug combination therapy for renal cell carcinoma
  

  Poster Presenter: Yoshinari Muto, MD – Fujita Health University
• 7:00 AM – 9:00 AM CST

  MP04-12: Pharmacological inhibition of the molecular chaperone Hsp70 overcomes Belzutifan resistance in ccRCC
  

  Poster Presenter: Michael Fred Basin, MD
• 7:00 AM – 9:00 AM CST

  MP04-13: Immunophenotype Analysis of Tumor-infiltrating Immune Cells to Elucidate the Mechanism of Antitumor Effect of IL-7 and CCL19 Producing CAR-T Cells against Solid Cancer
  

  Poster Presenter: Shunsuke Goto, MD, PHD – Kyushu University
• 7:00 AM – 9:00 AM CST

  MP04-14: T Cell and B Cell Receptor Sequencing Reveals anti-cancer immune response associated with immune-related adverse events in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors
  

  Poster Presenter: Taigo Kato, MD, PhD (he/him/his) – Osaka University Graduate School Of Medicine
• 7:00 AM – 9:00 AM CST

  MP04-15: Multi-Region Sampling of Localized Renal Cell Carcinoma Tumors Demonstrates PD-L1 Expression Heterogeneity And Prognostic Ability To Identify Risk Of Metastatic Progression
  

  Poster Presenter: Daniel Shapiro, MD (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP04-16: Epithelial to mesenchymal transition promotes PD-L1 expression in renal cell carcinoma
  

  Poster Presenter: Allison May, MD
• 7:00 AM – 9:00 AM CST

  MP04-17: Alterations in RNASET2 Facilitate a Pro Tumor Microenvironment Associated with Worse Clinical Outcomes in Clear Cell RCC
  

  Poster Presenter: Taylor Peak
• 7:00 AM – 9:00 AM CST

  MP04-18: Leveraging patient-derived renal cell carcinoma organoids to enrich tumor-reactive T cells and identify novel immune checkpoints
  

  Poster Presenter: Laura Zuluaga
• 7:00 AM – 9:00 AM CST

  MP04-19: Impact of Surgery on Cytotoxic Activity of Patient-driven CD8 T cell
  

  Poster Presenter: Reza Nabavizadeh, MD (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP04-20: Characterization of Mitochondrial Dysfunction in Models of Renal Oncocytoma
  

  Poster Presenter: Lin Lin, MD, PHD – UCLA